Doorduyn Y, de Jager C M, van der Zwaluw W K, Wannet W J B, van der Ende A, Spanjaard L, van Duynhoven Y T H P
Center for Infectious Diseases Epidemiology, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.
Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):433-42. doi: 10.1007/s10096-006-0157-4.
In order to add to the limited data available about the incidence of invasive Listeria monocytogenes infection in the Netherlands, two studies were conducted. In the first study, data on hospital patients with listeriosis in the period 1995-2003 were obtained from the National Medical Registration (study 1). In the second study, hospital discharge letters for patients whose Listeria isolates were received by the Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM) in the period 1999-2003 were retrieved (study 2). Serotyping and pulsed-field gel electrophoresis (PFGE) were used to subtype the various strains of Listeria. These reviews revealed 283 hospital patients and 159 patients with Listeria isolates. Discharge letters were received for 107 (67%) patients. The mean annual incidence of listeriosis in both studies was 2.0 per million inhabitants. The main clinical manifestations were meningitis (incidence: 0.9 and 1.0 per million in studies 1 and 2, respectively) and septicaemia (incidence: 0.08 and 1.0 per million, respectively). Listeriosis in pregnancy was rare (incidence: 1.3 and 2.4 per 100,000 pregnancies over 24 weeks of gestation, respectively). Predisposing conditions were present in 47 and 71% of the patients in studies 1 and 2, respectively. The mortality due to listeriosis was 18%. Serotypes 4b, 1/2a, and 1/2b were responsible for 96% of the cases of human listeriosis. Listeriosis is rare in the Netherlands, but its clinical course is severe and the resulting mortality is high. Therefore, the current recommendations for pregnant women to avoid high-risk foods should be continued. These dietary recommendations should also be given to individuals with predisposing conditions, since they, too, are at risk of Listeria infection.
为了补充荷兰侵袭性单核细胞增生李斯特菌感染发病率方面有限的数据,开展了两项研究。在第一项研究中,从国家医疗登记处获取了1995年至2003年期间患李斯特菌病的住院患者的数据(研究1)。在第二项研究中,检索了1999年至2003年期间荷兰细菌性脑膜炎参考实验室(NRLBM)收到李斯特菌分离株的患者的出院信件(研究2)。使用血清分型和脉冲场凝胶电泳(PFGE)对各种李斯特菌菌株进行亚型分析。这些综述共发现283例住院患者和159例有李斯特菌分离株的患者。收到了107例(67%)患者的出院信件。两项研究中李斯特菌病的年平均发病率均为每百万居民2.0例。主要临床表现为脑膜炎(发病率:研究1和研究2中分别为每百万0.9例和1.0例)和败血症(发病率:分别为每百万0.08例和1.0例)。妊娠期间的李斯特菌病很罕见(发病率:妊娠24周以上分别为每10万例妊娠1.3例和2.4例)。研究1和研究2中分别有47%和71%的患者存在易感因素。李斯特菌病导致的死亡率为18%。血清型4b、1/2a和1/2b导致了96%的人类李斯特菌病病例。李斯特菌病在荷兰很罕见,但其临床病程严重,死亡率很高。因此,目前建议孕妇避免食用高风险食物的建议应继续执行。这些饮食建议也应给予有易感因素的个体,因为他们也有感染李斯特菌的风险。